Hotline:0731-28580280

Detailed

20 Registration Certificate Number Xiangqi Zhuzhun 20222141159
Registrant Name Hunan Xinxie Kang Medical Equipment Co., Ltd
Registrant's domicile 3rd Floor, Building 10, Innovation and Entrepreneurship Center, No. 31 Dongfeng Road, Xiangtan Economic Development Zone
Production Address 3rd Floor, Building 10, Innovation and Entrepreneurship Center, No. 31 Dongfeng Road, Xiangtan Economic Development Zone
Product name Medical recombinant type III humanized collagen liquid dressing
Management Category the second category
Model 0.5mL/bottle, 1mL/bottle, 1.5mL/bottle, 2mL/bottle, 3mL/bottle, 5mL/bottle, 10mL/bottle, 15mL/bottle, 20mL/bottle, 25mL/bottle, 30mL/bottle, 40mL/bottle, 50mL/bottle, 60mL/bottle, 80mL/bottle, 100mL/bottle, 120mL/bottle, 150mL/bottle, 200mL/bottle.
Structure and Composition/Main Components The product is composed of recombinant type III humanized collagen, methylcellulose, glycerol, p-hydroxyphenylethanone, 1,2-hexanediol, poloxamer, and purified water, packaged in PET plastic or glass bottles. The product is provided sterile after irradiation sterilization.
Scope of application/intended use Suitable for the care of non chronic wounds (such as superficial wounds, postoperative suture wounds, mechanical wounds, small wounds, abrasions, cutting wounds, puncture sites of puncture instruments, I degree or shallow II degree burn wounds, and wounds after laser/photon/fruit acid skin exchange/micro plastic surgery), providing a microenvironment for wound healing. Adjuvant treatment for skin inflammation caused by factors such as sores and laser therapy can promote skin repair, shorten the course of the disease, reduce the risk of pigmentation and scar formation after inflammation, improve the skin, and delay skin aging.
Product storage conditions and expiration date
Attachment Product Technical Requirements
Other content Other content
Remark
Approval department Hunan Provincial Drug Administration
Approval Date 2022/6/24
Effective Date 2022/6/24
Valid until 2027/6/23
Change situation On August 14, 2025 at 08:23:55, the structure and composition stated in the registration certificate are composed of "recombinant type III humanized collagen protein, methylcellulose, glycerol, p-hydroxyphenylethanone, 1,2-hexanediol, poloxamer, and purified water, packaged in PET plastic or glass bottles. The product is provided sterile after irradiation sterilization. ”Change to "The product is composed of recombinant type III humanized collagen, methylcellulose, glycerol, p-hydroxyphenylethanone, 1,2-hexanediol, poloxamer, and purified water, packaged in PET plastic bottles, glass bottles, or aluminum bottles. The product is provided sterile after irradiation sterilization. ”2. Please refer to the instruction manual change comparison table for details on the instruction manual changes.